SIC
CLPT icon

Salem Investment Counselors’s ClearPoint Neuro CLPT Stock Holding History

Salem Investment Counselors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446 Hold
25
– – ﹤0.01% 1192
2026
Q1 		$228 Buy
+25
New +$316 ﹤0.01% 1202

Other funds holding CLPT

PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
LWM
Lodestone Wealth Management Spokane, Washington $283M AUM 33.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Salem Investment Counselors's CLPT Position: Q2 2026 in Review

Salem Investment Counselors held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 25 shares worth $446. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Salem Investment Counselors first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Salem Investment Counselors held 25 shares of ClearPoint Neuro worth $446 as of Q2 2026.
  • Salem Investment Counselors left its ClearPoint Neuro share count unchanged in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1192 holding.
  • Salem Investment Counselors first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.